Guggenheim Upgrades MacroGenics (MGNX) to Buy
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Price: $4.32 --0%
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 11
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 11
Join SI Premium – FREE
Guggenheim analyst Charles Zhu upgraded MacroGenics (NASDAQ: MGNX) from Neutral to Buy with a price target of $12.00.
For an analyst ratings summary and ratings history on MacroGenics click here. For more ratings news on MacroGenics click here.
Shares of MacroGenics closed at $6.37 yesterday.
You May Also Be Interested In
- BofA Securities Upgrades Cintas (CTAS) to Buy
- Deutsche Bank Upgrades B&M European Value Retail SA (BME:LN) (BMRRY) to Hold
- Kotak Upgrades Hindalco Industries Limited (HNDL:IN) to Buy (1)
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
